“…In particular, the growth of sex/gender research in pharmacology has stimulated the commissioning of a BJP Themed Issue on this topic in 2019. In this themed issue alone, there are reviews and original articles demonstrating that sex is an important determinant of physiology, disease phenotype, and drug response from diverse systems of the body spanning across schizophrenia (Gogos, Ney, Seymour, Van Rheenen, & Felmingham, 2019), fear sensation (Clark et al, 2019) to metabolism (Henstridge, Abildgaard, Lindegaard, & Febbraio, 2019) and obesity (Taylor, Ramirez, Musail, & Sullivan, 2019). A focus upon sex driving diversity in drug response is also evident from the literature: Recent examples include that airway smooth muscle, isolated from obese females, manifests greater agonist‐induced excitation–contraction coupling than those derived from lean males, females, or from obese males (Orfanos et al, 2018) and that sex differences in the thermoregulatory and behavioural responses to the CNS stimulant, cathinone (Alsufyani & Docherty, 2017), have been identified.…”